BYLTORO Trademark

Trademark Overview

On Friday, July 10, 2020, a trademark application was filed for BYLTORO with the United States Patent and Trademark Office. The USPTO has given the BYLTORO trademark a serial number of 90046921. The federal status of this trademark filing is REGISTERED as of Tuesday, August 31, 2021. This trademark is owned by Takeda Pharmaceuticals International AG. The BYLTORO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology
byltoro

General Information

Serial Number90046921
Word MarkBYLTORO
Filing DateFriday, July 10, 2020
Status700 - REGISTERED
Status DateTuesday, August 31, 2021
Registration Number6466595
Registration DateTuesday, August 31, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Pharmaceuticals International AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH
Party NameTakeda Pharmaceuticals International AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH
Party NameTakeda Pharmaceuticals International AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Trademark Events

Event DateEvent Description
Tuesday, August 31, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 27, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, June 25, 2021NOTICE OF ALLOWANCE CANCELLED
Monday, July 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 25, 2021TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 2, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 25, 2021ASSIGNED TO LIE
Wednesday, November 25, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 25, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 25, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, November 25, 2020SUSPENSION LETTER WRITTEN
Tuesday, November 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 26, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 26, 2020NON-FINAL ACTION E-MAILED
Monday, October 26, 2020NON-FINAL ACTION WRITTEN
Wednesday, October 21, 2020ASSIGNED TO EXAMINER
Thursday, August 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 14, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

byltoro oncology preparations pharmaceutical